Section A: External Beam Radiation Therapy (Teletherapy) and Brachytherapy

1. Thames HD Jr, Withers WR, Peters LJ, et al: Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships, Int J Radiat Oncol Biol Phys 8:219, 1982. Medline abstracts
2. Kippenes H, Gavin PR, Parsaei H, et al: Spatial accuracy of fractionated IMRT delivery studies in canine paraspinal irradiation, Vet Radiol Ultrasound 44:360, 2003. Medline abstracts
3. Pruitt AF, Thrall DE: Use of photon fields with noncoincident isocenters to improve homogeneity of dose distribution, Vet Radiol Ultrasound 45:471, 2004. Medline abstracts
4. Kippenes H, Gavin PR, Sande RD, et al: Accuracy of positioning the cervical spine for radiation therapy and the relationship to GTV, CTV, and PTV, Vet Radiol Ultrasound 44:714, 2003. Medline abstracts
5. Walker M, Durrer R, Weir V, et al: A study to evaluate single port, central axis dosimetry and verification techniques for veterinary radiotherapy, using the canine nasal cavity as a model target, Vet Radiol 35:210, 1994.
6. McEntee MC, Page RL, Novotney CA, et al: Palliative radiotherapy for canine appendicular osteosarcoma, Vet Radiol 34:367, 1993.
7. Northup NC: Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors, J Am Anim Hosp Assoc 40:309, 2004. Medline abstracts
8. Thompson JP: 192 iridium brachytherapy, using an intracavitary afterload device, for   treatment of intranasal neoplasms in dogs, Am J Vet Res 53:17, 1992. Medline abstracts
9. Hammond GM: Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 cases (1990-2006), J Am Vet Med Assoc 231:736, 2007. Medline abstracts
10. Turrel JM: Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992-2002), J Am Vet Med Assoc 228:898, 2006. Medline abstracts

Section B: Radioisotopes in Cancer Therapy

1. McCoig AM, Henry CJ, Milner RJ, et al: Use of Samarium-153-EDTMP for the treatment of 21 dogs with primary tumors of the skull, Vet Comp Oncol 3:111, 2005 (abstract).
2. Lattimer JC, Corwin LA Jr, Stapleton J, et al: Clinical and clinicopathologic response of canine bone tumors patients to treatment with Samarium-153-EDTMP, J Nucl Med 31:1316, 1990. Medline abstracts
3. Milner RJ, Dormehl I, Louw WK, et al: Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours, J S Afr Vet Assoc 69:12, 1998. Medline abstracts
4. Henry CJ: Radiopharmaceutical treatment of canine osteosarcoma, Symposium on canine osteosarcoma, Veterinary Cancer Society Mid-Year Conference, 2006, p 50.
5. Barnard SM, Zuber RM, Moore AS: Samarium SM 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005), J Am Vet Med Assoc 230:1877, 2007. Medline abstracts
6. Lattimer JC, Corwin LA Jr, Stapleton J et al: Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs, J Nucl Med 31:586, 1990. Medline abstracts
7. Turrel JM, McEntee MC, Burke BP, et al: Sodium iodide I 131 treatment of dogs with nonresectable thyroid tumors: 39 cases (1990-2003), J Am Vet Med Assoc 229:542, 2006. Medline abstracts
8. Guptill L, Scott-Moncrieff CR, Janovitz EB, et al: Response to high-dose radioactive iodine administration in cats with thyroid carcinoma that had previously undergone surgery, J Am Vet Med Assoc 207:1055, 1995. Medline abstracts
9. Turrel JM, Feldman EC, Nelson RW, et al: Thyroid carcinoma causing hyperthyroidism in cats: 14 cases (1981-1986), J Am Vet Med Assoc 193:359, 1988. Medline abstracts
10. Smith M, Turrel JM: Radiophosphorus (32P) treatment of bone marrow disorders in dogs: 11 cases (1970-1987), J Am Vet Med Assoc 194:98, 1989. Medline abstracts

Section C: Management of Radiation Toxicity and Complications

1. Hall EJ: Predictive assays. In Hall EJ (ed): Radiobiology for the radiologist. Philadelphia, 2000, Lippincott, Williams & Wilkins.
2. LaDue T, Klein MK: Toxicity criteria of the veterinary radiation therapy oncology group, Vet Rad Ultrasound 42:475, 2001. Medline abstracts
3. Hall EJ: Time, dose, and fractionation in radiotherapy. In Hall EJ (ed): Radiobiology for the radiologist. Philadelphia, 2000, Lippincott Williams and Wilkins.
4. McEntee MC, Page RL, Theon A, et al: Malignant tumor formation in dogs previously irradiated fro acanthomatous epulis, Vet Rad Ultrasound 45:357, 2004. Medline abstracts
5. Pajonk F, Riedisser A, Henke M, et al: The effects of tea extracts on proinflammatory signaling, BMC Med 4:28, 2006. Medline abstracts
6. McEntee MC: Veterinary radiation therapy: review and current state of the art, J Am Anim Hosp Assoc 42:94, 2006. Medline abstracts